Viewing Study NCT01548118


Ignite Creation Date: 2025-12-25 @ 5:02 AM
Ignite Modification Date: 2025-12-26 @ 4:03 AM
Study NCT ID: NCT01548118
Status: UNKNOWN
Last Update Posted: 2012-03-08
First Post: 2012-02-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females
Sponsor: Shanghai Zerun Biotechnology Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module